Jupiter Life Line Q2FY27 consolidated PAT Rs 56.4 cr on total income Rs 456.5 cr
Results$JLHL

Jupiter Life Line Q2FY27 consolidated PAT Rs 56.4 cr on total income Rs 456.5 cr

Jupiter Life Line Hospitals’ consolidated total income was Rs 456.50 cr and PAT Rs 56.40 cr in Q2FY27, versus Rs 393.60 cr and Rs 57.40 cr in Q2FY26.

Jupiter Life Line Hospitals LtdReviewed and published by · How we report
3 min read
jupiter life lineq2fy27 resultshospitalearningspat
ShareWhatsAppXLinkedIn

Key takeaways

  • Total income was Rs 456.50 cr in Q2FY27, up from Rs 393.60 cr in Q2FY26.
  • Revenue from operations rose to Rs 436.30 cr in Q2FY27 from Rs 376.80 cr a year earlier.
  • EBITDA increased to Rs 106.90 cr in Q2FY27 versus Rs 92.20 cr in Q2FY26.
  • PAT was Rs 56.40 cr in Q2FY27 compared with Rs 57.40 cr in Q2FY26.
  • Basic EPS stood at 1.72 in Q2FY27 against 1.75 in Q2FY26.

Q2FY27 · consolidated

MetricSep 2026Sep 2025Change
RevenueRs 436.30 crRs 376.80 cr+15.8%
PATRs 56.40 crRs 57.40 cr-1.7%

As reported in the filing. Figures are transcribed, not computed.

What the numbers show

  • Net margin was 12.93% of revenue, down 230 bps from 15.23%.

• Basis and period: All figures are consolidated, taken from the consolidated profit & loss statement for the quarter ended Q2FY27 (three months ended September 30, 2026), compared with Q2FY26.

• Revenue from operations: Rs 436.30 cr in Q2FY27, up from Rs 376.80 cr in Q2FY26.

• Other income – operational: Rs 20.20 cr in Q2FY27, compared with Rs 16.80 cr in Q2FY26.

• Total income: Rs 456.50 cr in Q2FY27, versus Rs 393.60 cr in Q2FY26.

• Cost of goods sold: Rs 86.50 cr in Q2FY27, compared with Rs 73.80 cr in Q2FY26.

• Gross profit: Rs 370.00 cr in Q2FY27, versus Rs 319.80 cr in Q2FY26.

• Employee cost: Rs 81.30 cr in Q2FY27, up from Rs 63.20 cr in Q2FY26.

• Professional fees: Rs 110.20 cr in Q2FY27, compared with Rs 103.00 cr in Q2FY26.

• Other expenses: Rs 71.60 cr in Q2FY27, versus Rs 61.40 cr in Q2FY26.

• EBITDA: Rs 106.90 cr in Q2FY27, up from Rs 92.20 cr in Q2FY26.

• Depreciation: Rs 28.50 cr in Q2FY27, compared with Rs 21.50 cr in Q2FY26.

• EBIT: Rs 78.40 cr in Q2FY27, versus Rs 70.70 cr in Q2FY26.

• Other income – finance: Rs 10.50 cr in Q2FY27, compared with Rs 11.30 cr in Q2FY26.

• Finance cost: Rs 13.80 cr in Q2FY27, up from Rs 7.80 cr in Q2FY26.

• Exceptional item gain / (loss): Rs 0.00 cr in Q2FY27, unchanged from Rs 0.00 cr in Q2FY26.

• PBT: Rs 75.10 cr in Q2FY27, compared with Rs 74.20 cr in Q2FY26.

• Tax: Rs 18.70 cr in Q2FY27, versus Rs 16.80 cr in Q2FY26.

• PAT: Rs 56.40 cr in Q2FY27, compared with Rs 57.40 cr in Q2FY26.

• Basic EPS: 1.72 in Q2FY27, versus 1.75 in Q2FY26.

In the consolidated profit & loss statement, Jupiter Life Line Hospitals reported higher revenue from operations and total income in Q2FY27 versus the same quarter last year. Revenue from operations rose to Rs 436.30 cr from Rs 376.80 cr, while total income increased to Rs 456.50 cr from Rs 393.60 cr. Gross profit also moved up to Rs 370.00 cr from Rs 319.80 cr. On the cost side, employee cost, professional fees and other expenses all increased year-on-year, with employee cost at Rs 81.30 cr versus Rs 63.20 cr, professional fees at Rs 110.20 cr versus Rs 103.00 cr, and other expenses at Rs 71.60 cr versus Rs 61.40 cr.

EBITDA improved to Rs 106.90 cr in Q2FY27 from Rs 92.20 cr in Q2FY26, and EBIT rose to Rs 78.40 cr from Rs 70.70 cr. Depreciation increased to Rs 28.50 cr from Rs 21.50 cr, and finance cost rose to Rs 13.80 cr from Rs 7.80 cr, while other income – finance was Rs 10.50 cr versus Rs 11.30 cr. With no exceptional gain or loss reported in either period, profit before tax was Rs 75.10 cr in Q2FY27 compared with Rs 74.20 cr in Q2FY26. After tax of Rs 18.70 cr (versus Rs 16.80 cr a year earlier), profit after tax stood at Rs 56.40 cr in Q2FY27, marginally lower than Rs 57.40 cr in Q2FY26. Basic EPS for the quarter was 1.72, compared with 1.75 in the corresponding quarter of the previous year.

Track Jupiter Life Line Hospitals Ltd

Cruxal reads every Jupiter Life Line Hospitals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Get every filing that moves a stock

One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.

Cruxal publishes market coverage for information only. Nothing here is investment advice.